Hansen Medical Featured in Live Case Transmission During Heart Rhythm
Congress 2007
Patient Suffering From Atrial Fibrillation to Be Treated Utilizing
Robotic Catheter Navigation System
LONDON--(Marketwire - October 29, 2007) - Hansen Medical, Inc.
(NASDAQ: HNSN) announced today that its Sensei(TM) Robotic Catheter
System will be used during a complex ablation procedure to treat
atrial fibrillation that will be transmitted live during the Heart
Rhythm Congress 2007.
The live case will be transmitted from the Wessex Cardiothoracic
Centre at the Southampton General Hospital, October 30, 9:00 a.m., to
the Congress' main auditorium at the Hilton Birmingham Metropole
Hotel.
During the procedure, Wyn Davies, M.D., consultant cardiologist for
St. Mary's Hospital of London, and his team will use the Sensei
system to guide an ablation catheter in the treatment of a patient
suffering from atrial fibrillation (AF). In addition, Professor John
Morgan, consultant cardiologist at Southampton General Hospital will
be in attendance. According to the European Society of Cardiology
(ESC), AF is the most common heart rhythm disturbance and it
increases the risk for stroke, heart failure and all causes of death,
especially in women.
"We will use the revolutionary robotic catheter navigation system to
guide and accurately control the catheters during this complex
ablation procedure," said Dr. Davies. "I have been using the Sensei
technology in my clinical practice because it allows for precision
and control of catheter movement, which is difficult to achieve
manually. During this case we will demonstrate how this exciting
advance offers the potential to treat more patients suffering from AF
and ultimately reduce their clinical risk associated with this
condition."
With the Sensei system, physicians of differing skill level are able
to successfully employ this remote catheter navigation system within
their practices. Additionally, physicians in the European Union are
able to combine the use of the Sensei system's remote navigation
capability with state-of-the-art irrigated catheters to deliver more
effective therapy during complex cardiac procedures.
In Europe, Hansen Medical is the only company to provide robotic
control of irrigated ablation catheter technology for atrial
fibrillation because its remote navigation system has an open
architecture. This open architecture permits the use of irrigated
catheters from third party manufacturers, which are approved to treat
atrial fibrillation in Europe. Irrigated catheters prevent the
formation of dangerous clots on the tip of the catheter during
ablation procedures. As a result of this technology, ablation
procedures and treatment in Europe are more effective and the risk of
stroke is expected to be significantly decreased. The combination of
the Sensei system's ability to accurately position catheters at
targeted cardiac anatomy along with the more effective lesions
created by irrigated catheters should have a powerful effect on
procedure outcomes.
"The prevalence of AF in Europe and worldwide is growing and we feel
it is imperative that electrophysiologists of all skill levels are
equipped with effective solutions to help them detect, diagnose and
treat heart disease earlier," said Frederic Moll, M.D., founder and
CEO of Hansen Medical. "The adoption of our technology into treatment
centers of varying sizes is extremely encouraging to us in our
efforts to help improve clinical outcomes."
Hansen Medical has installed a total of five Sensei(TM) Robotic
Catheter systems in the United States and four in Europe since
receiving both FDA and CE Mark clearance in May 2007. The
installation sites range from large teaching institutions and
university medical centers to community hospitals.
The Sensei system is designed to allow physicians to place mapping
catheters in hard-to-reach anatomical locations within the heart
easily, accurately and with stability during the diagnostic phase of
complex cardiac arrhythmia treatment. The system is compatible with
fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram
data.
About Hansen Medical, Inc.
Hansen Medical, based in Mountain View, Calif., was founded in 2002
to develop products and technology using robotics for the accurate
positioning, manipulation and stable control of catheters and
catheter-based technologies. Additional information can be found at
www.hansenmedical.com.
This press release contains forward-looking statements that are
subject to a number of risks and uncertainties, including statements
about the potential for success and timing of sales in the United
States and Europe of the Sensei System and Artisan Control Catheter.
Actual results may differ materially from those set forth in this
press release due to the risks and uncertainties inherent in our
business, including potential safety issues; the scope of potential
use of our products; the scope and validity of intellectual rights
applicable to our products; competition from other companies; our
ability to obtain additional financing to support our operations; our
ability to successfully launch and market our product; and other
risks detailed in the "Risk Factors" section of our Quarterly Report
on Form 10Q for the quarter ended June 30, 2007. We undertake no
obligation to revise or update information herein to reflect events
or circumstances in the future, even if new information becomes
available.
Hansen Medical has pending trademark applications for "Hansen
Medical," "Sensei," "Artisan," "Hansen Artisan," as well as the
Hansen Medical "heart design" logo.
Media Contact:
Amy Cook
925.552.7893
amy_cook@hansenmedical.com
Investor Contact:
Steven Van Dick
650.404.5800
steve_vandick@hansenmedical.com
--- End of Message ---
Hansen Medical, Inc.
380 North Bernardo Avenue Mountain View United
States of America
WKN: A0LHLD; ISIN: US4113071017;
;
